
Jessica Kim Cohen
Precision Medicine Reporter at GenomeWeb
precision medicine reporter at @GenomeWeb (@CrainComm) 🧬 + president at @AAJA_Chicago 📰 | formerly: tech reporter at @modrnhealthcr
Articles
-
Jan 14, 2025 |
precisionmedicineonline.com | Jessica Kim Cohen
NEW YORK – Intellia Therapeutics expects to commercialize its first three therapeutic indications by 2030, the company's CEO said Monday at the JP Morgan Healthcare Conference in San Francisco.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 2K
- Tweets
- 3K
- DMs Open
- Yes

RT @BlockClubCHI: Bridgeport’s Zhou B Art Center is hosting a Black History Month Festival of the Arts. https://t.co/DlMmfnUWE3 https://t.c…

RT @PrecMedOnline: Intellia Readying for Commercial Activities, First Product Launch in 2027 https://t.co/BTXOPIlEMp https://t.co/4boSQAK5Ie

RT @PrecMedOnline: African, Asian Ancestry Patients Less Likely to Be Eligible for New Precision Oncology Drugs https://t.co/fTjF5Jf7tC